NCT00140595View on ClinicalTrials.gov

ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1

PHASE3CompletedINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Diffuse Large-Cell Lymphoma
Interventions
DRUG

rituximab

DRUG

doxorubicin

DRUG

cyclophosphamide

Trial Locations (10)

31059

Hématologie CHU Purpan, Toulouse

51092

Centre Hospitalier Robert Debré, Reims

69008

Centre Léon Bérard, Lyon

69495

Service d'Hématologie - Centre Hospitalier Lyon-Sud, Pierre-Bénite

75010

Hôpital Saint Louis, Paris

75743

Hématologie Adultes - Hôpital Necker, Paris

76038

Centre Henri Becquerel, Rouen

94010

Hôpital Henri Mondor, Créteil

Unknown

Groupe d'étude des lymphomes de l'adulte, Yvoir

Institut Gustave Roussy, Villejuif

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Lymphoma Study Association

OTHER